| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.01 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |